Years of Suprabodies development
Potential disease areas
Suprabodies discovered
Scientific publications
Inger Therapeutics
At Inger Therapeutics, we are driven by our passion for peptide-based ligands called Suprabodies. Our team is dedicated to developing and broadening the druggable realm in key disease areas.
Our goal is to offer our selection platform to biotech companies to identify hit molecules in an accelerated time frame.
Our Passion: Suprabodies
Novel platform for Biotech innovation
Accelerating Biotech Innovation
Versatility in application
Partnering for success
Inspired from nature, Our platform employs an unique 'reshuffling' during selection similar to antibodies, enabling the ability to evolve high affinity binders - Suprabodies. We are committed to using our platform to develop new ligands that enable Life science and Biotech companies globally
Our selection platform is extremely quick and robust to discover ligands. This can significantly speed up the ligand development process and potentially make a significant difference in the patient's life.
Our passion supra-bodies Know More Novel platform for Biotech innovation Suprabodies have the potential to be utilized in a wide range of applications such as in Therapeutics, Diagnostics, Theranostics or Delivery vehicles. At Inger Therapeutics, we are exploring various disease areas where Suprabodies can make a significant impact. Our team is passionate about finding new ways to use Suprabodies to improve human health. Accelerating Biotech Innovation Versatility in application Partnering for success
We believe that collaboration is key to success in the biotech industry. We are always looking for new partnerships with biotech companies who share our passion for innovation and improving human health.
Inspired from nature, Our platform employs an unique 'reshuffling' during selection similar to antibodies, enabling the ability to evolve high affinity binders - Suprabodies. We are committed to using our platform to develop new ligands that enable Life science and Biotech companies globally
Our selection platform is extremely quick and robust to discover ligands. This can significantly speed up the ligand development process and potentially make a significant difference in the patient's life.
Our passion supra-bodies Know More Novel platform for Biotech innovation Suprabodies have the potential to be utilized in a wide range of applications such as in Therapeutics, Diagnostics, Theranostics or Delivery vehicles. At Inger Therapeutics, we are exploring various disease areas where Suprabodies can make a significant impact. Our team is passionate about finding new ways to use Suprabodies to improve human health. Accelerating Biotech Innovation Versatility in application Partnering for success
We believe that collaboration is key to success in the biotech industry. We are always looking for new partnerships with biotech companies who share our passion for innovation and improving human health.
Partnering For Success
Our robust suprabody screening platform has a range of applications for pharmaceutical companies, biotechnology companies and academic partners to cater the needs of ligand discovery in rapidly expanding disease targets.
If you are interested in ligand discovery for any protein of interest, do not hesitate to reach us.
We are funded by
